杀菌剂二元混合物的联合相互作用:实验研究和机器学习驱动的QSAR建模
Mohsen Abbod1, Ahmad Mohammad2
1Department of Plant Protection, Faculty of Agriculture, Al-Baath University, Homs, Syria. abbod.mohsen111@gmail.com.
Scientific reports
|June 3, 2024
概括
杀菌剂混合物有效地延迟了耐药性. 这项研究开发了预测模型,发现人工神经网络 (ANN) 在设计强效杀菌组合以对抗耐药性方面优越.
科学领域:
- 农业科学 农业科学
- 计算化学计算化学
- 植物病理学 植物病理学
背景情况:
- 抗真菌杀菌剂耐药性是农作物生产的主要威胁.
- 混合策略对于控制真菌杀菌剂耐药性至关重要.
- 预测建模可以优化有效杀菌剂混合物的开发.
研究的目的:
- 评估二元真菌杀菌剂混合物的杀菌活性和相互作用.
- 开发和比较量化结构-活性关系 (QSAR) 模型,以预测杀菌效果.
- 确定最佳的杀菌剂组合,以延迟杀菌剂耐药性.
主要方法:
- 使用固定比率射线设计生成了50种二元真菌杀菌剂混合物.
- 使用组合分析 (CA) 和干扰分析 (IA) 模型分析混合物相互作用.
- 使用多重线性回归 (MLR),支持向量机 (SVM) 和人工神经网络 (ANN) 来进行QSAR建模.
主要成果:
- 大多数杀真菌剂混合物都表现出添加物相互作用.
- 在预测杀菌活性方面,CA模型比IA模型更准确.
- 基于机器学习 (ML) 的模型 (ANN和SVM) 在预测性能方面表现优于MLR.
- 与SVM (R2=0.91,R2cv=0.78,R2test=0.77) 相比,ANN模型显示出更高的可预测性 (R2=0.91,R2cv=0.81,R2test=0.845),而SVM则显示出更高的可预测性.
结论:
- 基于ML的QSAR模型是设计有效的杀菌剂混合物的宝贵工具.
- 开发的ANN模型显示了预测杀菌活性和指导耐药性管理策略的巨大潜力.
- 优化杀真菌剂组合是可持续农业和缓解耐药性发展的关键.
更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
Quantitative Aspects of Drug-Receptor Interaction
2.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.2K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
119
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
119
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Methods of Medium Optimization
70
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
70
Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119


